Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Nihon Kohden
- Study ID
- NCT05441696
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ezCVP measurement — DEVICE* Measuring device: non-FDA-cleared patient monitor (740E, Zoe Medical, MA, US), which has software to measure ezCVP. * Sensor: an FDA-cleared pulse oximeter sensor for adults (K012891: DS-100A, Nellcor, CA, US). * Cuff: an FDA-cleared NIBP cuff for adults (K080342: YP-713T, YP-714T or TP-715T, Nihon Kohden Corporation, Tokyo, Japan).
Study Details
Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission
Key Dates
- Start date
- Jun 1, 2022
- Status verified
- Mar 2024
- Primary completion
- Sep 30, 2025
- Completion
- Sep 29, 2026
Study Design
- Enrollment
- 65 participants (estimated)
Arms
- Arm: Adult CHF subjects with initial high CVPAdult subjects with congestive heart failure diagnosis who have an indicated high non-invasive estimated central venous pressure on first measurement after clinical unit admission.
- Arm: Adult CHF subjects with initial low CVPAdult subjects with congestive heart failure diagnosis who have an indicated low non-invasive estimated central venous pressure on first measurement after clinical unit admission.
Primary Outcome Measure
Evaluate the difference between non-invasive CVP measurement at admission and at discharge [ Time Frame: 7 days ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Veterans Affairs Hospital | Palo Alto | California | 94304 | - |
| Stanford Medical Center | Stanford | California | 94305 | - |
Find similar trials in Palo Alto, CA
By condition
By specialty
Related Studies
- Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection FractionPHASE1/PHASE2 · Recruiting · Sardocor Corp. · San Diego, California
- Circulating Markers for Ischemic Heart DiseaseRecruiting · UConn Health · Farmington, Connecticut
- Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart DiseaseRecruiting · University of Utah · Murray, Utah
- Stress and Congestive Heart FailureRecruiting · Yale University · Hartford, Connecticut